Agree this is big news - to me, it indicates the growing need for API, meaning sales are either bigger than we think or the management believes the recent addition of V to major formularies is going to drive sales higher quickly. This is essentially equal to adding a 2nd or 3rd shift to a production line, and you don't do that unless you have a product in high demand.
Whoa, let's not get ahead of yourselves. The last manufacturing "change" letter was to create a bottle for samples. Might have nothing to do with sNDA for a supplier. On the flip side, Novasep let slip a document saying that they were contracted in a hurry due to sudden increase in demand for API and that's likely for ANCHOR projections. They have already said they are building the world's largest chromatography facility specifically for Amarin and Slanmhor.
News 
Market Data 
Discover 
